First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
暂无分享,去创建一个
Robert N. Taylor | M. Wolf | V. Sukhatme | R. Levine | R. Thadhani | J. Ecker | W. Mutter | S. Karumanchi | R. Taylor | Richard J. Levine | M. Wolf
[1] E. Seely,et al. Insulin resistance and its potential role in pregnancy-induced hypertension. , 2003, The Journal of clinical endocrinology and metabolism.
[2] D. Saller,et al. Second‐Trimester Maternal Serum Placental Growth Factor and Vascular Endothelial Growth Factor for Predicting Severe, Early‐Onset Preeclampsia , 2003, Obstetrics and gynecology.
[3] Y. Taketani,et al. Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. , 2003, The Journal of clinical endocrinology and metabolism.
[4] T. Libermann,et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .
[5] R. Romero,et al. Maternal serum of women with pre-eclampsia reduces trophoblast cell viability: evidence for an increased sensitivity to Fas-mediated apoptosis , 2003, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[6] Robert N. Taylor,et al. Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies. , 2003, American journal of obstetrics and gynecology.
[7] P. Takacs,et al. Increased Endothelial Monocyte Chemoattractant Protein‐1 and Interleukin‐8 in Preeclampsia , 2002, Obstetrics and gynecology.
[8] D. Ginzinger,et al. Human placental vascular development: vasculogenic and angiogenic (branching and nonbranching) transformation is regulated by vascular endothelial growth factor-A, angiopoietin-1, and angiopoietin-2. , 2002, The Journal of clinical endocrinology and metabolism.
[9] S. Djurovic,et al. Absence of enhanced systemic inflammatory response at 18 weeks of gestation in women with subsequent pre‐eclampsia , 2002, BJOG : an international journal of obstetrics and gynaecology.
[10] P. Parfrey,et al. Familial risk of preeclampsia in Newfoundland: a population-based study. , 2002, Journal of the American Society of Nephrology : JASN.
[11] K. Alitalo,et al. Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. , 2002, The American journal of pathology.
[12] M. Wolf,et al. First trimester insulin resistance and subsequent preeclampsia: a prospective study. , 2002, The Journal of clinical endocrinology and metabolism.
[13] R. Resnik. Intrauterine growth restriction. , 2002, Obstetrics and gynecology.
[14] M. Wolf,et al. Obesity and preeclampsia: the potential role of inflammation. , 2001 .
[15] C. Oudejans,et al. Plasma Placenta Growth Factor Levels in Midtrimester Pregnancies , 2001, Obstetrics and gynecology.
[16] K. Nicolaides,et al. First‐Trimester Maternal Serum Levels of Placenta Growth Factor as Predictor of Preeclampsia and Fetal Growth Restriction , 2001, Obstetrics and gynecology.
[17] J. Roberts. Preeclampsia: Is There Value in Assessing Before Clinically Evident Disease? , 2001, Obstetrics and gynecology.
[18] S. Chow,et al. Decreased Maternal Serum Placenta Growth Factor in Early Second Trimester and Preeclampsia , 2001, Obstetrics and gynecology.
[19] C. Redman,et al. Expression of inflammatory cytokines in placentas from women with preeclampsia. , 2001, The Journal of clinical endocrinology and metabolism.
[20] B. Sibai,et al. Placenta growth factor is not an early marker for the development of severe preeclampsia. , 2001, American journal of obstetrics and gynecology.
[21] H. Ho,et al. Low maternal serum levels of placenta growth factor as an antecedent of clinical preeclampsia. , 2001, American journal of obstetrics and gynecology.
[22] R. Thadhani,et al. Pulse Pressure and Risk of Preeclampsia: A Prospective Study , 2001, Obstetrics and gynecology.
[23] Jm Roberts,et al. Pathogenesis and genetics of pre-eclampsia , 2001, The Lancet.
[24] B. Sibai,et al. Reductions of vascular endothelial growth factor and placental growth factor concentrations in severe preeclampsia. , 2000, American journal of obstetrics and gynecology.
[25] James J. Walker,et al. Pre-eclampsia , 2000, The Lancet.
[26] S. Fisher,et al. The glial cells missing-1 protein is essential for branching morphogenesis in the chorioallantoic placenta , 2000, Nature Genetics.
[27] G. Wallukat,et al. AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. , 2000, Circulation.
[28] S. Kauma,et al. The Journal of Clinical Endocrinology & Metabolism Printed in U.S.A. Copyright © 1999 by The Endocrine Society Hepatocyte Growth Factor Stimulates Trophoblast Invasion: A Potential Mechanism for Abnormal , 2022 .
[29] A. Duits,et al. Selective deficit of angiogenic growth factors characterises pregnancies complicated by pre‐eclampsia , 1999 .
[30] J. Manson,et al. High body mass index and hypercholesterolemia: risk of hypertensive disorders of pregnancy. , 1999, Obstetrics and gynecology.
[31] L. Poston,et al. Effect of antioxidants on the occurrence of pre-eclampsia in women at increased risk: a randomised trial , 1999, The Lancet.
[32] T. H. Wang,et al. Preeclampsia is associated with reduced serum levels of placenta growth factor. , 1998, American journal of obstetrics and gynecology.
[33] K. Conrad,et al. Circulating Levels of Immunoreactive Cytokines in Women with Preeclampsia , 1998, American journal of reproductive immunology.
[34] R. Jaffe,et al. Changes in Uterine Artery Doppler Velocimetry in Pregnant Patients Undergoing Glucose Tolerance Test May Predict Adverse Outcome in Later Pregnancy: A Preliminary Study , 1998, Fetal Diagnosis and Therapy.
[35] B. Sibai,et al. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. , 1998, The New England journal of medicine.
[36] M. Lindheimer,et al. Preeclampsia selectively impairs endothelium-dependent relaxation and leads to oscillatory activity in small omental arteries. , 1998, The Journal of clinical investigation.
[37] R. Kaaja. Insulin Resistance Syndrome in Preeclampsia , 1998, Seminars in reproductive endocrinology.
[38] S. Fisher,et al. Regulation of human placental development by oxygen tension. , 1997, Science.
[39] Y. Sadovsky,et al. The expression and activity of prostaglandin H synthase-2 is enhanced in trophoblast from women with preeclampsia. , 1997, The Journal of clinical endocrinology and metabolism.
[40] J. Cutler,et al. Trial of calcium to prevent preeclampsia. , 1997, The New England journal of medicine.
[41] H. Granger,et al. Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. , 1997, Laboratory investigation; a journal of technical methods and pathology.
[42] D. Charnock-Jones,et al. VEGF mRNA levels in placentae from pregnancies complicated by pre‐eclampsia , 1996, British journal of obstetrics and gynaecology.
[43] B. Sibai. Treatment of hypertension in pregnant women. , 1996, The New England journal of medicine.
[44] Jeffrey R. Wilson,et al. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women , 1994, The Lancet.
[45] A. Conde-Agudelo,et al. Evaluation of methods used in the prediction of hypertensive disorders of pregnancy. , 1994, Obstetrical & gynecological survey.
[46] B. Sibai,et al. Prevention of preeclampsia with low‐dose aspirin in healthy, nulliparous pregnant women , 1993, The New England journal of medicine.
[47] James M. Roberts,et al. Pre-eclampsia: more than pregnancy-induced hypertension , 1993, The Lancet.
[48] S. Sidney,et al. A multivariate analysis of risk factors for preeclampsia. , 1991 .
[49] B. Sibai,et al. Early detection of preeclampsia. , 1991, American journal of obstetrics and gynecology.
[50] J. Laragh,et al. Hypocalciuria in preeclampsia. , 1987, The New England journal of medicine.
[51] T. Khong,et al. Inadequate maternal vascular response to placentation in pregnancies complicated by pre‐eclampsia and by small‐for‐gestational age infants , 1986 .
[52] E. Baráth,et al. Fundamentals of Biostatistics. , 1992 .
[53] C. Redman,et al. PLASMA-URATE MEASUREMENTS IN PREDICTING FETAL DEATH IN HYPERTENSIVE PREGNANCY , 1976, The Lancet.